Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Toll-like receptor 7/8 agonist
PARP1/2 inhibitor.
Macrolide; protein translation inhibitor, mamma...
HDAC6 inhibitor.
NK1 antagonist.
Potential voltage-gated Na+ channel blocker.
PI3K and mTOR inhibitor.
Alters membrane permeability and Ca2+ signaling...
Benzisoxazole; 5-HT7 and NMDA agonist, D-amino ...
Quaternary ammonium cationic surfactant, dissoc...
Actinomycin derivative used to study apoptosis ...
Antimicrobial peptide found in Apis mellifera.<...
Aureothricin is a member of the dithiolopyrrolo...
Loratadine metabolite; FIASMA, histamine H1 ant...
Polyketide; CRM1 inhibitor.
mGluR5 positive modulator.
PDE4 inhibitor.
Endogenous peptide, involved in immune signalin...
Triterpenoid